title: Evaluation of ABO blood groups as a risk factor for myocardial infarction.
authors.forename: Irena
authors.initials: I
authors.lastname: Jukic
authors.forename: Jasna
authors.initials: J
authors.lastname: Bingulac-Popovic
authors.forename: Vesna
authors.initials: V
authors.lastname: Dogic
authors.forename: Ana
authors.initials: A
authors.lastname: Hecimovic
authors.forename: Ivana
authors.initials: I
authors.lastname: Babic
authors.forename: Ivanka
authors.initials: I
authors.lastname: Batarilo
authors.forename: Cedomir
authors.initials: C
authors.lastname: Maglov
authors.forename: Deana
authors.initials: D
authors.lastname: Sturm
mesh_terms: D000017:ABO Blood-Group System / Q000235:genetics*; D000328:Adult; D000483:Alleles; D019943:Amino Acid Substitution; D005165:Factor V / Q000235:genetics*; D005260:Female; D005787:Gene Frequency / Q000235:genetics; D006801:Humans; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D008875:Middle Aged; D020125:Mutation, Missense; D009203:Myocardial Infarction / Q000235:genetics*
chemical_list: D000017:ABO Blood-Group System; C095381:factor V Leiden; D005165:Factor V; C573423:MTHFR protein, human; D042965:Methylenetetrahydrofolate Reductase (NADPH2)